RETRACTED: A new compound of thiophenylated pyridazinone IMB5043 showing potent antitumor efficacy through ATM-Chk2 pathway

Jianhua Gong; Yanbo Zheng; Ying Wang; Weijin Sheng; Yi Li; Xiujun Liu; Shuyi Si; Rongguang Shao; Yongsu Zhen

doi:10.1371/journal.pone.0191984

Loading metrics

Open Access

Peer-reviewed

Research Article

RETRACTED: A new compound of thiophenylated pyridazinone IMB5043 showing potent antitumor efficacy through ATM-Chk2 pathway

Jianhua Gong,

Roles Conceptualization, Project administration, Writing – original draft

Affiliation Department of Oncology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
⨯
Yanbo Zheng,

Roles Conceptualization, Project administration, Writing – original draft

Affiliation Department of Oncology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
⨯
Ying Wang,

Roles Project administration

Affiliation Department of Oncology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
⨯
Weijin Sheng,

Roles Project administration

Affiliation Department of Oncology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
⨯
Yi Li,

Roles Project administration

Affiliation Department of Oncology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
⨯
Xiujun Liu,

Roles Project administration

Affiliation Department of Oncology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
⨯
Shuyi Si,

Roles Resources

Affiliation Department of Oncology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
⨯
Rongguang Shao,

Roles Writing – review & editing

Affiliation Department of Oncology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
⨯
Yongsu Zhen

Roles Conceptualization, Writing – review & editing

* E-mail: zhenys@imb.pumc.edu.cn

Affiliation Department of Oncology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
⨯

RETRACTED: A new compound of thiophenylated pyridazinone IMB5043 showing potent antitumor efficacy through ATM-Chk2 pathway

Jianhua Gong,
Yanbo Zheng,
Ying Wang,
Weijin Sheng,
Yi Li,
Xiujun Liu,
Shuyi Si,
Rongguang Shao,
Yongsu Zhen

Published: February 2, 2018
https://doi.org/10.1371/journal.pone.0191984

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Apoptosis
Is the Subject Area "Apoptosis" applicable to this article?

Thanks for your feedback.
DNA damage
Is the Subject Area "DNA damage" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Cell staining
Is the Subject Area "Cell staining" applicable to this article?

Thanks for your feedback.
Hepatocellular carcinoma
Is the Subject Area "Hepatocellular carcinoma" applicable to this article?

Thanks for your feedback.
Lung and intrathoracic tumors
Is the Subject Area "Lung and intrathoracic tumors" applicable to this article?

Thanks for your feedback.
Renal cancer
Is the Subject Area "Renal cancer" applicable to this article?

Thanks for your feedback.